11,698 Shares in DocuSign, Inc. (NASDAQ:DOCU) Bought by Alpha DNA Investment Management LLC

Alpha DNA Investment Management LLC bought a new stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,698 shares of the company's stock, valued at approximately $1,052,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rhumbline Advisers raised its position in shares of DocuSign by 118.8% in the 4th quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock valued at $54,695,000 after acquiring an additional 330,136 shares during the period. KBC Group NV raised its holdings in DocuSign by 32.7% in the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company's stock worth $138,067,000 after purchasing an additional 378,233 shares during the period. Jennison Associates LLC bought a new position in shares of DocuSign during the fourth quarter worth $12,897,000. Everence Capital Management Inc. acquired a new position in shares of DocuSign in the 4th quarter valued at $720,000. Finally, Principal Financial Group Inc. increased its position in shares of DocuSign by 3,026.7% in the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company's stock valued at $49,179,000 after buying an additional 529,308 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Insiders Place Their Bets

In related news, insider Robert Chatwani sold 15,706 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the completion of the sale, the insider now directly owns 76,842 shares of the company's stock, valued at approximately $6,392,485.98. This trade represents a 16.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now owns 77,851 shares of the company's stock, valued at $6,765,251.90. This trade represents a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 55,851 shares of company stock valued at $4,607,439 over the last 90 days. 1.66% of the stock is currently owned by insiders.

DocuSign Stock Down 1.3 %

Shares of DocuSign stock opened at $75.42 on Friday. The stock has a market cap of $15.27 billion, a P/E ratio of 15.55, a P/E/G ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The business's 50 day moving average is $81.60 and its 200-day moving average is $83.00.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same period in the prior year, the firm posted $0.76 earnings per share. The company's quarterly revenue was up 9.0% compared to the same quarter last year. On average, sell-side analysts expect that DocuSign, Inc. will post 1.17 EPS for the current year.

Analyst Ratings Changes

Several research analysts have weighed in on DOCU shares. Royal Bank of Canada reiterated a "sector perform" rating and set a $90.00 target price on shares of DocuSign in a report on Friday, March 14th. Morgan Stanley decreased their price objective on DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a research report on Wednesday. William Blair raised DocuSign from a "market perform" rating to an "outperform" rating in a research note on Monday, March 17th. Bank of America reduced their price target on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a report on Friday, March 14th. Finally, Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, DocuSign presently has a consensus rating of "Hold" and an average target price of $93.08.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.